Leo James and Michel Goedert, group leaders at the LMB, recently published work in PNAS providing an explanation for how therapeutic antibodies eliminate pathogenic forms of tau protein. Here, Alzforum explore the background, results and implications of this study. More…
Home > LMB In The News > Antibodies co-opt anti-microbial response to clear intraneuronal tau